Document Detail

Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher.
MedLine Citation:
PMID:  23380865     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Patients with Model for End-Stage Liver Disease (MELD) scores of 40 or higher are at high risk for liver transplantation. In some regions, the organ donor shortage has resulted in a substantial increase in the number of patients who underwent transplantation with MELD scores of 40 or higher. The objective of this study was to characterize the outcomes of liver transplantation in these patients.
METHODS: A single-center retrospective study evaluating the outcome of liver transplantation in 38 consecutive patients achieving a MELD score of 40 or higher from January 1, 2006, to November 30, 2010, was conducted. Patient and graft survivals and independent risk factors for postoperative death or graft loss were determined.
RESULTS: Kaplan-Meier-based 1-, 2-, and 3-year patient survival rates were 89%, 82%, and 77% with 1-, 2-, and 3-year graft survival rates of 84%, 75%, and 70.3%, respectively. One of three recipients was on a vasopressor before transplantation, and 13% were mechanically ventilated. Renal replacement therapy was used before operation in 90% of the recipients. Postoperative length of stay averaged 38 days. There was a 42% incidence of postoperative bacteremia and an 18% incidence of bile duct stricture within 6 months. Univariate analysis identified admission-to-transplantation time and recipient diabetes as risk factors for graft failure and patient death. Multivariate analysis confirmed recipient diabetes as a risk factor for patient survival and admission-to-transplantation time of more than 15 days as a risk factor for graft survival.
CONCLUSIONS: Acceptable outcomes are achievable after liver transplantation in patients with MELD scores of 40 or higher but come at high pretransplantation and posttransplantation resource utilization.
Sophoclis Alexopoulos; Lea Matsuoka; Yong Cho; Elizabeth Thomas; Mohd Sheikh; Maria Stapfer; Kiran Dhanireddy; Linda Sher; Rick Selby; Yuri Genyk
Related Documents :
24628975 - Carbon monoxide-releasing molecule attenuates allograft airway rejection.
2951605 - Hypocomplementemic vasculitis and renal involvement.
23297075 - Development and evaluation of 18f-ttco-cys40-exendin-4: a pet probe for imaging transpl...
15841645 - Autologous punch grafting for vitiligo of the palm.
3985165 - Maleate-induced stimulation of glutamine metabolism in the intact dog kidney.
11598445 - Role of percutaneous image-guided biopsy in the evaluation of renal masses.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation     Volume:  95     ISSN:  1534-6080     ISO Abbreviation:  Transplantation     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-02-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0132144     Medline TA:  Transplantation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  507-12     Citation Subset:  IM    
1 Division of Hepatobiliary and Pancreatic Surgery and Abdominal Organ Transplantation, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA. 2 Address correspondence to: Sophoclis Alexopoulos, M.D., Division of Hepatobiliary and Pancreatic Surgery and Abdominal Organ Transplantation, Department of Surgery, Keck School of Medicine, University of Southern California, 1510 San Pablo St, Ste 200, Los Angeles, CA 90033.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Vildagliptin and Pioglitazone in Patients With Impaired Glucose Tolerance After Kidney Transplantati...
Next Document:  Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm.